Brief: Deciphera Pharmaceuticals, Inc. Announces Publication Of Intrigue Phase 3 Clinical Study Results In Journal Of Clinical Oncology
10/08/2022 21:27
Aug 10 (Reuters) - Deciphera Pharmaceuticals Inc DCPH.O :
* DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES PUBLICATION OF
INTRIGUE PHASE 3 CLINICAL STUDY RESULTS IN JOURNAL OF CLINICAL
ONCOLOGY
Source text for Eikon: ID:nBwbkSNx4a
Further company coverage: DCPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions